|
Clinical group
|
Genotype
|
Pre-S2 S tart codon
|
Deletions
|
---|
| | | |
Region
|
Nucleotides
|
Amino acids
|
Region and functions affected
|
---|
ID
| | | | |
Size
|
Position
|
Size
|
position
| |
---|
SDAC024
|
CR
|
D
|
ATG
|
Pre-S2
|
21
|
35-55a
|
7
|
16-22a
| |
SDAC048
|
CR
|
D
|
ATG
|
Pre-S1
|
72
|
2998-3069
|
24
|
51-74
|
S promoter, Transactivator domain
|
SDAC083
|
CR
|
D
|
ATG
|
Pre-S2
|
21
|
35-55
|
7
|
16-22
| |
SDAC097
|
CR
|
D
|
GTG
b
|
Pre-S 2
|
9
|
45- 53
|
3
|
19-21
| |
SDAC098
|
CH
|
D
|
ATG
|
Pre-S1
|
18
|
3129-3146
|
6
|
94-99
|
Hsc70 binding site, CCAAT binding factor (CBF) binding site, Cytosolic anchorage determinant (CAD)
|
SDAC112
|
ASC
|
D
|
ATG
|
Pre-S2
|
6
|
49-54
|
2
|
20-21
| |
SDAC118
|
CR
|
D
|
ATG
|
Pre-S2
|
54
|
4-57
|
18
|
5 to 22
|
pHSA binding site, Viral secretion
|
SDAC107
|
CR
|
D
|
ATA
|
-
|
-
|
-
|
-
|
-
|
-
|
SDAC090
|
CR
|
D
|
ATA
|
-
|
-
|
-
|
-
|
-
|
-
|
SDAC058
|
CR
|
E
|
ATG
|
Pre-S2
|
9
|
58-66c
|
3
|
20-22c
|
Transactivator domain
|
SDAC059
|
HCC
|
E
|
GTG
|
Pre-S2
|
12
|
52-63
|
4
|
18-21
|
Transactivator domain
|
SDAC088
|
HCC
|
E
|
ATG
|
Pre-S2
|
12
|
52-63
|
4
|
18-21
|
Transactivator domain
|
SDAC095
|
HCC
|
E
|
ATG
|
Pre-S2
|
15
|
52-66
|
5
|
18-22
|
Transactivator domain
|
SDAC067
|
ASC
|
E
|
GTG
|
-
|
-
|
-
|
-
|
-
|
-
|
SDAC113
|
ASC
|
A
|
ACA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
a nucleotide or amino acid position relative to genotype D (GU456684).
-
b mutant pre-S2 start codon italicized.
-
c nucleotide or amino acid position relative to genotype E (AB205191).